PHARMACIE BURDIGALA : revenue, balance sheet and financial ratios

PHARMACIE BURDIGALA is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BORDEAUX (33000), this company of category PME shows in 2024 a revenue of 986 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE BURDIGALA (SIREN 531033975)
Indicator 2025 2024 2023 2022 2021 2019 2018 2017 2016
Revenue N/C 985 642 € 907 310 € 891 775 € 830 328 € N/C N/C N/C N/C
Net income -15 002 € 29 553 € 56 183 € 132 601 € 18 762 € 9 824 € 62 900 € 63 760 € 67 398 €
EBITDA N/C 30 382 € 75 845 € 203 926 € 42 647 € N/C N/C N/C N/C
Net margin N/C 3.0% 6.2% 14.9% 2.3% N/C N/C N/C N/C

Revenue and income statement

In 2025, PHARMACIE BURDIGALA records a net loss of 15 k€. This deficit will reduce equity on the balance sheet.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-15 002 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 17%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

17.378%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

57.735%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

27.3%

Solvency indicators evolution
PHARMACIE BURDIGALA

Sector positioning

Debt ratio
17.38 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good

In 2025, the debt ratio of PHARMACIE BURDIGALA (17.38) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
57.73% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good -20 pts over 3 years

In 2025, the financial autonomy of PHARMACIE BURDIGALA (57.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
1.39 years 2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Good +8 pts over 2 years

In 2024, the repayment capacity of PHARMACIE BURDIGALA (1.39) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 131.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

131.688

Liquidity indicators evolution
PHARMACIE BURDIGALA

Sector positioning

Liquidity ratio
131.69 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average -50 pts over 3 years

In 2025, the liquidity ratio of PHARMACIE BURDIGALA (131.69) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
2.15x 2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Average +19 pts over 2 years

In 2024, the interest coverage of PHARMACIE BURDIGALA (2.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 507 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 1120 days. Excellent situation: suppliers finance 613 days of the operating cycle (retail model).

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

507 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

1120 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE BURDIGALA

Positioning of PHARMACIE BURDIGALA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE BURDIGALA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE BURDIGALA

What is the revenue of PHARMACIE BURDIGALA ?

The revenue of PHARMACIE BURDIGALA in 2024 is 986 k€.

Is PHARMACIE BURDIGALA profitable?

PHARMACIE BURDIGALA recorded a net loss in 2025.

Where is the headquarters of PHARMACIE BURDIGALA ?

The headquarters of PHARMACIE BURDIGALA is located in BORDEAUX (33000), in the department Gironde.

Where to find the tax return of PHARMACIE BURDIGALA ?

The tax return of PHARMACIE BURDIGALA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE BURDIGALA operate?

PHARMACIE BURDIGALA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.